Zandberg DP, Zenkin S, Ak M, Mamindla P, et al. Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti-PD-1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients. Head Neck 2024 Jul 30. doi: 10.1002/hed.27878.
PMID: 39080968